IN2011CH01039A - - Google Patents

Info

Publication number
IN2011CH01039A
IN2011CH01039A IN1039CH2011A IN2011CH01039A IN 2011CH01039 A IN2011CH01039 A IN 2011CH01039A IN 1039CH2011 A IN1039CH2011 A IN 1039CH2011A IN 2011CH01039 A IN2011CH01039 A IN 2011CH01039A
Authority
IN
India
Application number
Inventor
Ragnar Hovland
Morten Braendvang
Anne Kristin Holmeide
Original Assignee
Pronova Biopharma Norge As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40419454&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2011CH01039(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pronova Biopharma Norge As filed Critical Pronova Biopharma Norge As
Publication of IN2011CH01039A publication Critical patent/IN2011CH01039A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/61—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C313/00—Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C313/02—Sulfinic acids; Derivatives thereof
    • C07C313/04—Sulfinic acids; Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/54—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/55—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/56—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
IN1039CH2011 2008-07-15 2011-02-14 IN2011CH01039A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8080408P 2008-07-15 2008-07-15
EP08160450A EP2147910A1 (en) 2008-07-15 2008-07-15 Novel lipid compounds

Publications (1)

Publication Number Publication Date
IN2011CH01039A true IN2011CH01039A (en) 2011-12-30

Family

ID=40419454

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1039CH2011 IN2011CH01039A (en) 2008-07-15 2011-02-14

Country Status (29)

Country Link
US (3) US8759558B2 (en)
EP (2) EP2147910A1 (en)
JP (1) JP5628164B2 (en)
KR (2) KR101901836B1 (en)
CN (1) CN102159200B (en)
AU (1) AU2009271791B2 (en)
BR (1) BRPI0916456B8 (en)
CA (1) CA2730958C (en)
CL (2) CL2011000090A1 (en)
CO (1) CO6341548A2 (en)
DK (1) DK2313090T3 (en)
EA (1) EA022593B1 (en)
ES (1) ES2573977T3 (en)
HK (1) HK1161078A1 (en)
HR (1) HRP20160557T1 (en)
HU (1) HUE029195T2 (en)
IL (1) IL210673A (en)
IN (1) IN2011CH01039A (en)
MA (1) MA33083B1 (en)
MX (1) MX2011000556A (en)
MY (1) MY153620A (en)
NZ (2) NZ590645A (en)
PH (1) PH12011500113A1 (en)
PL (1) PL2313090T3 (en)
SG (1) SG192525A1 (en)
UA (1) UA109252C2 (en)
VN (1) VN28144A1 (en)
WO (1) WO2010008299A1 (en)
ZA (1) ZA201100666B (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2733353T3 (en) 2007-11-09 2019-11-28 Basf As Lipid compounds for use in cosmetic products, as a food supplement or as a medicine
EP2147910A1 (en) 2008-07-15 2010-01-27 Pronova BioPharma Norge AS Novel lipid compounds
NZ618734A (en) * 2009-05-08 2015-01-30 Pronova Biopharma Norge As Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
HUE055712T2 (en) 2010-05-21 2021-12-28 Coors Brewing Co Preparation of hop acids and their derivatives
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
CA2809958A1 (en) 2010-08-31 2012-03-08 Snu R & Db Foundation Use of the fetal reprogramming of a ppar ? agonist
GB201014633D0 (en) 2010-09-02 2010-10-13 Avexxin As Rheumatoid arthritis treatment
NZ610705A (en) * 2010-11-05 2014-10-31 Pronova Biopharma Norge As Methods of treatment using lipid compounds
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en) 2011-09-27 2015-10-21 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
KR101390589B1 (en) * 2012-05-30 2014-04-30 가천대학교 산학협력단 Composition for preventing or treating diabetes comprising diamines
US11351139B2 (en) 2013-02-28 2022-06-07 Basf As Composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same
GB201313238D0 (en) 2013-07-24 2013-09-04 Avexxin As Process for the preparation of a polyunsaturated ketone compound
GB201501144D0 (en) * 2015-01-23 2015-03-11 Avexxin As Process for the preparation of a polyunsaturated ketone compound
WO2016173923A1 (en) 2015-04-28 2016-11-03 Pronova Biopharma Norge As Use of structurally enhanced fatty acids containing sulphur for preventing and/or treating non-alcoholic steatohepatitis
GB201604316D0 (en) 2016-03-14 2016-04-27 Avexxin As Combination therapy
AU2017329957B2 (en) 2016-09-21 2020-05-07 Avexxin As Pharmaceutical composition
EP3661600A4 (en) * 2017-10-23 2021-08-11 Epitracker, Inc. Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome
CA3084728A1 (en) 2017-12-06 2019-06-13 Basf As Fatty acid derivatives for treating non-alcoholic steatohepatitis
WO2019222254A1 (en) * 2018-05-16 2019-11-21 Epitracker, Inc. Compositions and methods for diagnosis and treatment of conditions related to aging
JP2021525249A (en) 2018-05-23 2021-09-24 エピトラッカー インコーポレイテッドＥｐｉｔｒａｃｋｅｒ， Ｉｎｃ． Compositions and Methods for Diagnosis and Treatment of Conditions Related to Aging and Long-Term Quality
CA3101041A1 (en) * 2018-05-23 2019-11-28 Northsea Therapeutics B.V. Structurally modified fatty acids for improving glycemic control and treating inflammatory bowel disease
WO2020236009A1 (en) * 2019-05-20 2020-11-26 T Omega As Fatty acid compounds for prevention and treatment of mitochondrial dysfunction
AU2020405549A1 (en) * 2019-12-19 2022-08-11 Liminal Biosciences Limited Cycloalkyl-containing carboxylic acids and uses thereof

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909554A (en) * 1956-07-23 1959-10-20 Monsanto Chemicals Process for the manufacture of (alkylmercapto) alkyl sulfates
GB1038723A (en) 1962-03-26
JPS4839001B1 (en) * 1970-11-09 1973-11-21
US4040781A (en) * 1974-06-06 1977-08-09 Lever Brothers Company Novel 2-(alkylsulfinyl)ethyl sulfates and compositions employing same
US4032564A (en) * 1974-09-09 1977-06-28 Zoecon Corporation Esters of cyclopropylalkanols
GB1523276A (en) 1974-09-20 1978-08-31 Lafon Labor Sulphur-containing amino compounds
US4009211A (en) * 1975-07-29 1977-02-22 Gulf Research & Development Company Beta,beta-dialkylethylmercaptoethoxylate as new compounds
US4209410A (en) * 1976-04-28 1980-06-24 Phillips Petroleum Company Lubricants
DE2861974D1 (en) * 1977-11-11 1982-09-16 Ciba Geigy Ag Pyridine dicarboxylic acid derivatives, their mixtures with metallic stabilisers and their use in stabilising chlorine-containing thermoplasts
JPS5570841A (en) * 1978-11-24 1980-05-28 Konishiroku Photo Ind Co Ltd Forming method of dye image
US4368190A (en) * 1980-04-17 1983-01-11 Merck & Co., Inc. Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation
DE3164332D1 (en) 1980-10-21 1984-07-26 Boehringer Mannheim Gmbh Phospholipids that contain sulphur, process for their preparation and medicines containing these compounds
US4411808A (en) * 1982-08-04 1983-10-25 Exxon Research & Engineering Co. Multifunctional additive for power transmission shift fluids
US4775223A (en) 1984-09-20 1988-10-04 Canon Kabushiki Kaisha Lactic acid derivative, liquid crystal composition containing same and liquid crystal device
CA2010000A1 (en) * 1989-04-07 1990-10-07 Paul B. Merkel Photographic recording material containing a cyan dye-forming coupler
JPH0451149A (en) * 1990-06-19 1992-02-19 Fuji Photo Film Co Ltd Silver halide color photographic sensitive material
FR2663928B1 (en) 1990-06-27 1994-04-08 Norsolor NOVEL SULFUR ACRYLIC COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND THEIR APPLICATION TO THE SYNTHESIS OF NEW POLYMERS.
JPH0543529A (en) * 1991-08-10 1993-02-23 Taisho Pharmaceut Co Ltd Alkaneamide ammonium compound
US5328952A (en) * 1992-02-14 1994-07-12 Rohm And Haas Company Multi-stage polymer latex cement modifier and process of making
JP2755279B2 (en) * 1992-03-19 1998-05-20 三井化学株式会社 Thermoplastic resin composition and molded article thereof
JP2793458B2 (en) * 1992-03-19 1998-09-03 三井化学株式会社 Polyamide resin composition for connector and connector
DE69431596T4 (en) * 1993-06-10 2003-10-30 University Of North Carolina At Chapel Hill, Chapel Hill (PHOSPHO) LIPIDS TO COMBAT HEPATITIS B INFECTION
JP3110918B2 (en) * 1993-06-18 2000-11-20 富士写真フイルム株式会社 Silver halide photographic material
DK70295A (en) * 1994-07-01 1996-01-02 Ciba Geigy Ag Titanium and zirconium complexes of carboxylic acids as corrosion inhibitors
WO1996011908A1 (en) * 1994-10-13 1996-04-25 Peptide Technology Limited Modified polyunsaturated fatty acids
US7517858B1 (en) * 1995-06-07 2009-04-14 The Regents Of The University Of California Prodrugs of pharmaceuticals with improved bioavailability
FR2741619B1 (en) * 1995-11-28 1998-02-13 Pf Medicament NOVEL 2,3,5-TRIMETHYL-4-HYDROXY-ANILIDES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
JP2000508645A (en) 1996-04-12 2000-07-11 ペプテック リミテッド Method for treating immune diseases using polyunsaturated fatty acids
US6060515A (en) * 1997-01-24 2000-05-09 The Regents Of The University Of California Treatment of skin conditions by use of PPARα activators
AU7240398A (en) * 1998-05-08 1999-11-29 Rolf Berge Use of non-beta-oxidizable fatty acid analogues for treatment of syndrome-x conditions
FR2786187B1 (en) * 1998-11-19 2001-11-09 Univ Paris Curie 2-ACYLAMINO-2-DEOXY-GLUCONO-1,5-LACTONE TYPE COMPOUNDS, PROCESS FOR OBTAINING SAME, COMPOSITIONS COMPRISING SAME AND USES THEREOF
FR2792312B1 (en) * 1999-04-15 2001-06-08 Oreal THIA-ALCYNOIC (POLY) COMPOUNDS AND DERIVATIVES THEREOF, COMPOSITIONS COMPRISING SAME AND THEIR USE
US6723717B1 (en) * 1999-06-01 2004-04-20 The University Of Texas Southwestern Medical Center Sulfur-containing thyroxane derivatives and their use as hair growth promotors
WO2000072920A1 (en) 1999-06-01 2000-12-07 The University Of Texas Southwestern Medical Center Substituted biaryl ether compounds
NO328803B1 (en) * 2000-03-03 2010-05-18 Thia Medica New fatty acid analogues
UA75083C2 (en) 2000-06-22 2006-03-15 Тераванс, Інк. Derivatives of glycopeptidephosphonates
FR2828487B1 (en) 2001-08-09 2005-05-27 Genfit S A NOVEL COMPOUNDS DERIVED FROM FATTY ACIDS, PREPARATION AND USES
AU2002361850A1 (en) * 2001-12-21 2003-07-30 3M Innovative Properties Company Medicinal aerosol formulations comprising ion pair complexes
GB2383355A (en) * 2001-12-22 2003-06-25 Schlumberger Holdings An aqueous viscoelastic fluid containing hydrophobically modified polymer and viscoelastic surfactant
BR0307265B1 (en) * 2002-01-31 2012-11-27 substantially solvent-free composition, concentrated emulsion, and process for treating and imparting water repellency to fibrous materials, leather, leather and textiles.
EP1551228B1 (en) * 2002-06-13 2012-10-03 New York University Synthetic c-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases
KR20050061400A (en) * 2002-06-20 2005-06-22 아이씨 벡 리미티드 Sulfur-containing phospholipid derivatives
FR2845991B1 (en) * 2002-10-16 2005-02-04 Pf Medicament ALPHA-PHENYL ACETANILIDE DERIVATIVES AND THEIR USE IN HUMAN THERAPEUTICS
US8372430B2 (en) * 2002-12-17 2013-02-12 The Procter & Gamble Company Compositions, methods, and kits useful for the alleviation of gastrointestinal effects
JPWO2004076404A1 (en) * 2003-02-28 2006-06-01 株式会社カネカ Method for producing optically active compound having substituent at 2-position
DE10326303A1 (en) * 2003-06-11 2004-12-30 Celares Gmbh Reagents for modifying biopharmaceuticals, their manufacture and use
AU2005209331A1 (en) 2004-01-30 2005-08-11 Peplin Biolipids Pty Ltd Therapeutic and carrier molecules
JP4563114B2 (en) 2004-08-30 2010-10-13 出光興産株式会社 Additive for lubricant
JP2008532971A (en) 2005-03-08 2008-08-21 チバ ホールディング インコーポレーテッド Metal oxide nanoparticles coated with specific phosphonates
CA2607247C (en) * 2005-05-04 2015-10-06 Pronova Biopharma Norge As .alpha.-substituted dha derivatives
WO2007116027A1 (en) 2006-04-12 2007-10-18 Unilever Plc Oral composition comprising a polyunsaturated fatty acid and salicylic acid for obtaining an antiinflammatory effect in skin
EP1849449A1 (en) * 2006-04-26 2007-10-31 3M Innovative Properties Company Filler containing composition and process for production and use thereof
US7763607B2 (en) * 2006-04-27 2010-07-27 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators
CA2652235A1 (en) * 2006-05-09 2007-11-22 Hemaquest Pharmaceuticals, Inc. Methods for treating blood disorders
US8399516B2 (en) 2006-11-01 2013-03-19 Pronova Biopharma Norge As Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (PPAR)
WO2008053340A1 (en) * 2006-11-03 2008-05-08 Pronova Biopharma Norge As A combination product comprising at least one lipid substituted in the alpha position and at least one hypoglycemic agent
CN101225064A (en) * 2007-01-19 2008-07-23 上海汇瑞生物科技有限公司 New method for preparing neta-thia-alpha-alkyl fatty acid
DE102007017179A1 (en) 2007-04-12 2008-10-23 Clariant International Ltd. Process for the preparation of Alkylpolyglykolcarbonsäuren and Polyglykoldicarbonsäuren by direct oxidation
ES2733353T3 (en) * 2007-11-09 2019-11-28 Basf As Lipid compounds for use in cosmetic products, as a food supplement or as a medicine
WO2009149496A1 (en) 2008-06-10 2009-12-17 Central Northern Adelaide Health Service Treatment of diabetes and complications thereof and related disorders
FR2933006B1 (en) 2008-06-27 2010-08-20 Inst Francais Du Petrole ABSORBENT SOLUTION CONTAINING SULFUR DEGRADATION INHIBITOR WITH CARBOXYL GROUPING AND METHOD FOR LIMITING THE DEGRADATION OF AN ABSORBENT SOLUTION
CN104000808A (en) 2008-07-08 2014-08-27 凯特贝希制药公司 Fatty acid acetylated salicylates and their uses
EP2147910A1 (en) 2008-07-15 2010-01-27 Pronova BioPharma Norge AS Novel lipid compounds
NZ618734A (en) 2009-05-08 2015-01-30 Pronova Biopharma Norge As Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
KR101685734B1 (en) * 2009-09-01 2016-12-12 카타베이시스 파마슈티칼즈, 인코포레이티드 Fatty acid niacin conjugates and their uses
CN102822141A (en) * 2010-01-20 2012-12-12 普罗诺瓦生物医药挪威公司 Salicylate fatty acid derivatives
NZ610705A (en) 2010-11-05 2014-10-31 Pronova Biopharma Norge As Methods of treatment using lipid compounds
WO2012115695A1 (en) 2011-02-25 2012-08-30 Catabasis Pharmaceuticals, Inc. Bis-fatty acid conjugates and their uses
WO2013016531A2 (en) 2011-07-26 2013-01-31 Purdue Research Foundation Compounds and methods for use in treating neoplasia and cancer

Also Published As

Publication number Publication date
NZ601501A (en) 2014-03-28
AU2009271791A1 (en) 2010-01-21
CL2011000090A1 (en) 2012-03-30
MY153620A (en) 2015-02-27
CL2018001111A1 (en) 2018-07-20
PH12011500113A1 (en) 2010-01-21
HRP20160557T1 (en) 2016-06-17
BRPI0916456B8 (en) 2021-05-25
HUE029195T2 (en) 2017-02-28
MA33083B1 (en) 2012-03-01
MX2011000556A (en) 2011-03-15
ES2573977T3 (en) 2016-06-13
US20140316002A1 (en) 2014-10-23
US8759558B2 (en) 2014-06-24
EA022593B1 (en) 2016-01-29
US20110190395A1 (en) 2011-08-04
KR20110031497A (en) 2011-03-28
SG192525A1 (en) 2013-08-30
BRPI0916456A2 (en) 2018-06-12
KR101901836B1 (en) 2018-09-27
WO2010008299A1 (en) 2010-01-21
EP2313090A4 (en) 2012-01-18
AU2009271791A2 (en) 2011-02-24
IL210673A (en) 2015-02-26
HK1161078A1 (en) 2012-08-24
CA2730958C (en) 2016-07-05
BRPI0916456B1 (en) 2020-12-29
DK2313090T3 (en) 2016-06-13
CN102159200B (en) 2015-06-24
NZ590645A (en) 2012-08-31
EP2313090A1 (en) 2011-04-27
VN28144A1 (en) 2011-12-26
IL210673A0 (en) 2011-03-31
UA109252C2 (en) 2015-08-10
US20170029368A1 (en) 2017-02-02
CO6341548A2 (en) 2011-11-21
PL2313090T3 (en) 2016-09-30
AU2009271791B2 (en) 2014-06-26
JP5628164B2 (en) 2014-11-19
EP2147910A1 (en) 2010-01-27
EA201170193A1 (en) 2011-08-30
EP2313090B1 (en) 2016-03-30
JP2011528350A (en) 2011-11-17
KR20170093253A (en) 2017-08-14
ZA201100666B (en) 2011-10-26
CN102159200A (en) 2011-08-17
CA2730958A1 (en) 2010-01-21

Similar Documents

Publication Publication Date Title
BR112016019572A2 (en)
BRPI0909040A2 (en)
BRPI0917573A2 (en)
BRPI0908549B8 (en)
BRPI0918697A2 (en)
BRPI0917525A2 (en)
BRPI0920750A2 (en)
BRPI0919470A2 (en)
BRPI0922455A2 (en)
BRPI0907698A2 (en)
BRPI0917618A8 (en)
BRPI0912727A2 (en)
BRPI0923734A2 (en)
BRPI0908285A2 (en)
BRPI0910485A2 (en)
BRPI0922669A2 (en)
BRPI0914750A2 (en)
BRPI0908120A2 (en)
BRPI0912462A2 (en)
BRPI0904541A8 (en)
BRPI0915616A2 (en)
BRPI0919811A2 (en)
BRPI0920914A2 (en)
BRPI0916284A2 (en)
BRPI0922550A2 (en)